Implantable systems for drug delivery to the brain

Ther Deliv. 2017 Dec;8(12):1097-1107. doi: 10.4155/tde-2017-0082.

Abstract

Most diseases and disorders of the brain require long-term therapy and a constant supply of drugs. Implantable drug-delivery systems provide long-term, sustained drug delivery in the brain. The present review discusses different type of implantable systems such as solid implants, in situ forming implants, in situ forming microparticles, depot formulations, polymeric-lipid implants, sucrose acetate isobutyrate and N-stearoyl L-alanine methyl ester systems for continuous drug delivery into brain for various brain diseases including glioblastomas, medulloblastoma, epilepsy, stroke, schizophrenia and Alzheimer's diseases. Implantable neural probes and microelectrode array systems for brain are also discussed in brief.

Keywords: CNS delivery; biodegradable implant; brain delivery; in situ forming microparticles; in situ forming implant; solid implants.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / pathology
  • Drug Carriers / chemistry*
  • Drug Implants / chemistry*
  • Glyburide / chemistry
  • Glyburide / therapeutic use
  • Humans
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / pathology
  • Polymers / chemistry
  • Protective Agents / chemistry
  • Protective Agents / therapeutic use
  • Stroke / drug therapy
  • Stroke / pathology

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Drug Implants
  • Polymers
  • Protective Agents
  • Glyburide